Nuclivision

Ghent, Belgium

Nuclivision provides novel radiotracers and treatments for oncology to help patients by improving the safety of nuclear medicine.

$5.7M raised

Apr 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nuclivision raised?

Nuclivision has raised $5.7M in total funding. The most recent round was Seed. The last funding was announced in April 2025.

Who are Nuclivision's investors?

Nuclivision's investors include LUMO labs, HERAN Partners, imec.istart Future Fund, Lumiares.

Where is Nuclivision headquartered?

Nuclivision is headquartered in Ghent, Belgium.

What does Nuclivision do?

Nuclivision provides novel radiotracers and treatments for oncology to help patients by improving the safety of nuclear medicine.

What stage is Nuclivision at?

Nuclivision is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2025.

MLA

"Nuclivision — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/nuclivision. Accessed July 4, 2026.

APA

VCBacked. (2025). Nuclivision — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/nuclivision

Wikipedia (cite web)

{{cite web |title=Nuclivision — Funding & Investors |url=https://www.vcbacked.co/company/nuclivision |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2025.